148396-Thumbnail Image.png
Description

Over time, tumor treatment resistance inadvertently develops when androgen de-privation therapy (ADT) is applied to metastasized prostate cancer (PCa). To combat tumor resistance, while reducing the harsh side effects of hormone therapy, the clinician may opt to cyclically alternates the patient’s treatment on and off.

540.35 KB application/pdf

Download restricted. Please sign in.

Download count: 0

Details

Contributors
Date Created
2021-05
Resource Type
  • Text
  • Machine-readable links